Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -11.00 (-1.32%)
Bid:
816.00
Ask:
822.00
Spread: 6.00 (0.735%)
Market Cap: £774.61m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AuM Update

13 Oct 2022 07:00

RNS Number : 7235C
Polar Capital Holdings PLC
13 October 2022
 

13 October 2022 Polar Capital Holdings plc

AuM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist active asset management group, today provides a quarterly update of its unaudited statement of Assets under Management ("AuM").

 

 

Group AuM (unaudited)

 

Polar Capital reports that as at 30 September 2022 its AuM were £18.8bn compared to £18.9bn at the end of the June quarter and £22.1bn at the end of March 2022. During the six-month period, AuM decreased by net redemptions of £0.8bn, outflows from previously reported fund closures of £0.5bn and a £2.0bn decrease related to market movement and fund performance.

 

AuM movement in six months to 30 September 2022

Open ended

funds

Investment

Trusts

Segregated mandates

Total

AuM at 1 April 2022

£16,590m

£4,378m

£1,153m

£22,121m

Net flows

£(753)m

£(62)m

£(30)m

£(845)m

Fund closures1

£(380)m

-

£(79)m

£(459)m

Market movement

and performance

£(1,374)m

£(611)m

£(66)m

£(2,051)m

Total AuM at

30 September 2022

£14,083m

£3,705m

£978m

£18,766m

1 Return of funds to investors on closure of the Phaeacian mutual funds and related segregated mandate in Q1.

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fee profits due to the Group (after the deduction of staff interests) as a product of accrued performance fees in funds managed by the Group three months before the strike point of such performance fee receipts. The majority of the Group's performance fees crystallise in the second half of the financial year. There is no certainty that the fees will be sustained over the next quarter, as performance fees can be volatile.

 

Performance fees

net of staff allocations

Six months to

30 Sept 21

Year to

31 Mar 22

(year-end)

Six months to

30 Sept 22

Received

-

£4.1m

-

Accrued but not yet earned in funds with year ends on or before the financial year end

£2m

n/a

£4.8m*

Total net performance fee profits

£2m

£4.1m

£4.8m*

\* The figures have been reduced by £1.0m of net performance fee distributions that relate to prior accounting periods that IFRS require to be deducted from this year's receipts.

 

 

Gavin Rochussen, Chief Executive, commented:

 

"There has been continued demand and inflows into the Global Insurance, Biotechnology, Healthcare Blue Chip, Smart Energy, European ex-UK Income, Emerging Market Stars, Forager and Global Absolute Return Funds, with combined net inflows of £260m across these funds in the quarter.

 

"A combination of the bear market sell-off, net outflows, fund closures and fund performance meant that our AuM at the end of the six-month period were £18.8bn compared to £18.9bn at the end of the previous quarter and £22.1bn at the end of March 2022. Total net outflows for the quarter were £529m.

 

"During the quarter, the rate of outflows from the open-ended Technology funds continued to decline, with £252m of outflows compared to £380m in the previous quarter and £630m in the first quarter of this calendar year. Outflows of £250m from the UK Value Opportunities Fund during the quarter reflected client asset allocation decisions with UK equity exposure being reduced.

 

"Despite the challenging back drop, we are pleased with the continuing progress in diversifying the business. The Smart funds managed by the Sustainable Thematic team have now collectively reached £150m. The Emerging Market Stars team have had success in the US with the Emerging Market Stars Mutual Fund raising its first £50m.

 

"The well-established Polar Capital Global Insurance fund has continued to deliver robust performance with net inflows of £257m in the six months. The team's low appetite for catastrophe risk has protected investor returns with the Fund well positioned to benefit from ongoing premium rate rises in commercial insurance and a recent acceleration in reinsurance pricing. For the calendar year to September 2022, the fund has achieved absolute positive performance of 12.2% which is 6.5% ahead of its benchmark.

 

"We remain confident that with our diverse range of differentiated, active specialist fund strategies we are well-positioned to perform for our clients and shareholders over the long term."

 

 

For further information please contact:

 

Polar Capital

Gavin Rochussen (Chief Executive)Samir Ayub (Finance Director)

+44 (0)20 7227 2700

 

Numis Securities Limited - Nomad and Joint Broker

Giles Rolls

Charles Farquhar

Stephen Westgate

 

 

+44 (0)20 7260 1000

 

 

Peel Hunt LLP - Joint Broker

Andrew Buchanan

 

 

+44 (0)20 3597 8680

 

Camarco

Ed Gascoigne-Pees

Jennifer Renwick

Phoebe Pugh

 

+44 (0)20 3757 4995

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAEEDFFFAFEA
Date   Source Headline
29th Jan 20265:15 pmRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20265:22 pmRNSTransaction in Own Shares
27th Jan 20263:50 pmRNSForm 8.3 - Beazley PLC
27th Jan 20261:03 pmRNSForm 8.3 - Beazley PLC
26th Jan 20265:13 pmRNSTransaction in Own Shares
23rd Jan 20265:07 pmRNSTransaction in Own Shares
22nd Jan 20265:27 pmRNSTransaction in Own Shares
21st Jan 20265:31 pmRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20261:45 pmRNSDirector/PDMR Shareholding
19th Jan 20265:12 pmRNSHolding(s) in Company
19th Jan 20265:08 pmRNSHolding(s) in Company
16th Jan 20267:01 amRNSShare Repurchase Programme - 2026
16th Jan 20267:00 amRNSAuM Update
12th Jan 20265:55 pmRNSHolding(s) in Company
9th Jan 20265:02 pmRNSHolding(s) in Company
6th Jan 20261:39 pmRNSDirector/PDMR Shareholding
17th Nov 20257:00 amRNSUnaudited Interim Results
3rd Nov 20257:00 amRNS-RNotice of Investor Presentation
13th Oct 20254:14 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSAuM Update
29th Sep 20252:08 pmRNSDirector/PDMR Shareholding
26th Sep 20257:00 amRNSDirectorate Change - Replacement
25th Sep 20254:54 pmRNSResult of AGM
25th Sep 20252:57 pmRNSDirectorate Change
12th Sep 20259:55 amRNSHolding(s) in Company
12th Sep 20257:00 amRNSDirector/PDMR Shareholding
21st Aug 202510:15 amRNSDirector/PDMR Shareholding
19th Aug 20253:26 pmRNSDirector/PDMR Shareholding
19th Aug 202511:08 amRNSDirector/PDMR Shareholding - Replacement
15th Aug 20259:42 amRNSDirector/PDMR Shareholding
1st Aug 20256:04 pmRNSForm 8.3 - Mitie Group PLC
1st Aug 20258:57 amRNSBlock listing Interim Review
31st Jul 202512:00 pmRNSForm 8.3 - Alpha Group International PLC
30th Jul 20255:25 pmRNSForm 8.3 - Mitie Group PLC
29th Jul 20255:09 pmRNSForm 8.3 - Alpha Group International PLC
28th Jul 20259:46 amRNSForm 8.3 - Mitie Group Plc
24th Jul 20255:23 pmRNSForm 8.3 - Mitie Group PLC
24th Jul 20255:21 pmRNSForm 8.3 - Alpha Group International PLC
24th Jul 202511:22 amRNSForm 8.3 - ALPHA GROUP INTERNATIONAL PLC
23rd Jul 202510:25 amRNSForm 8.3 - Mitie Group PLC
21st Jul 202512:38 pmRNSDirector/PDMR Shareholding
18th Jul 20252:43 pmRNSDirector/PDMR Shareholding
10th Jul 20257:00 amRNSAuM Update
7th Jul 20257:00 amRNSForm 8.3 - Alpha Group International PLC
30th Jun 20257:15 amRNSChange of Nominated Adviser
30th Jun 20257:01 amRNSGroup Audited Results for year ended 31 March 2025
30th Jun 20257:00 amRNSCEO Succession
27th Jun 202512:03 pmRNSForm 8.3 - Alpha Group International PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.